Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

Schippling, S; Kempf, C; Büchele, F; Jelcic, I; Bozinov, O; Bont, A; Linnebank, M; Sospedra, M; Weller, M; Budka, H; Martin, R (2013). JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment. Annals of Neurology, 74(4):622-626.

Jelcic, I; Aly, L; Binder, T M C; Jelcic, I; Bofill-Mas, S; Planas, R; Demina, V; Eiermann, T H; Weber, T; Girones, R; Sospedra, M; Martin, R (2013). T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donors. Journal of Virology, 87(6):3393-3408.

Jelcic, I; Hsu, K C; Kakalacheva, K; Breiden, P; Dupont, B; Uhrberg, M; Martin, R; Münz, C; Lünemann, J D (2012). Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis. Multiple Sclerosis, 18(7):951-958.

Lutterotti, A; Jelcic, I; Schulze, C; Schippling, S; Breiden, P; Mazzanti, B; Reinhardt, S; DiGioia, M; Repice, A; Massacesi, L; Sputtek, A; Salinas-Riester, G; Kroeger, N; Sospedra, M; Saccardi, R; Zander, A; Martin, R (2012). No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients. Multiple Sclerosis Journal, 18(8):1188-1192.

Kallweit, U; Jelcic, I; Braun, N; Fischer, H; Zörner, B; Schreiner, B; Sokolov, A A; Martin, R; Weller, M; Linnebank, M (2012). Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort. Clinical Neuropharmacology, 35(2):77-80.

Kühnlein, P; Jung, H H; Farkas, M; Keskitalo, S; Ineichen, B; Jelcic, I; Petersen, J; Semmler, A; Weller, M; Ludolph, A C; Linnebank, M (2011). The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is a possible risk factor for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 12(2):136-139.

Aly, L; Yousefi, S; Schippling, S; Jelcic, I; Breiden, P; Matschke, J; Schulz, R; Bofill-Mas, S; Jones, L; Demina, V; Linnebank, M; Ogg, G; Girones, R; Weber, T; Sospedra, M; Martin, R (2011). Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain: A Journal of Neurology, 134(Pt 9):2687-2702.

Conzett, K B; Kolm, I; Jelcic, I; Kamarachev, J; Dummer, R; Braun, R P; French, L E; Linnebank, M; Hofbauer, G F (2011). Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report. Archives of Dermatology, 147(8):991-992.

Lünemann, J D; Jelcic, I; Roberts, S; Lutterotti, A; Tackenberg, B; Martin, R; Münz, C (2008). EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. Journal of Experimental Medicine, 205(8):1763-1773.

This list was generated on Wed Sep 20 10:06:39 2017 CEST.